1 citations
,
January 2009 in “PubMed” PCOS affects many women and can cause various health issues, with several treatments available.
1 citations
,
October 2006 in “Oncology times” Finasteride improves prostate cancer detection in PSA test.
1 citations
,
November 2005 in “Journal of Andrology” The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.
Coconut oil penetrates hair and reduces protein loss, while mineral oil adds shine; choose oils based on desired effects for healthy hair.
April 2026 in “International Journal of Drug Delivery Technology” Histopathology is crucial for accurately diagnosing and predicting outcomes of skin adnexal tumors.
March 2026 in “Pakistan Armed Forces Medical Journal” Trichoscopy is useful for diagnosing and assessing androgenetic alopecia severity.
March 2026 in “IP Indian Journal of Clinical and Experimental Dermatology” Acne in women may indicate insulin resistance.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” The body can heal and achieve remarkable states through specific mind-body practices.
March 2026 in “European Urology Focus” Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.
March 2026 in “Cancer Diagnosis & Prognosis” Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.
March 2026 in “Gazzetta Medica Italiana Archivio per le Scienze Mediche” Finasteride effectively treats benign prostatic hyperplasia by reducing prostate size and improving urinary symptoms.
March 2026 in “Journal of Cosmetic Dermatology” Keratinocyte Growth Factor-Hair Serum may help prevent hair loss during chemotherapy, but more research is needed.
February 2026 in “Oncology Reviews” Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.
December 2025 in “The American Journal of Interdisciplinary Innovations and Research” The InvisiCaps Method ensures natural-looking hair extensions by carefully matching donor hair characteristics.
November 2025 in “Scientific Reports” AI improves accuracy and consistency in diagnosing male pattern hair loss.
Higher nitric oxide synthase levels in the scalp may influence hair loss in androgenetic alopecia.
October 2025 in “Australasian Journal of Dermatology” Combination therapies may be more effective for treating Folliculitis Decalvans than antibiotics alone.
October 2025 in “Journal of Cosmetic Dermatology” AOPT-MTL effectively and safely treats nasal blackheads in Asians.
July 2025 in “Chinese Journal of Dermatology” Certain N-glycans may help assess hair loss severity in men with female-pattern hair loss.
July 2025 in “The Journal of Dermatology” 5% topical minoxidil may help reduce hair loss and increase hair growth in telogen effluvium.
June 2025 in “British Journal of Dermatology” ALUDWIG can help standardize female hair loss assessment from a single image.
A natural, eco-friendly treatment using casein and tannic acid strengthens hair by 21% while keeping it elastic.
May 2025 in “CPT Pharmacometrics & Systems Pharmacology” A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.
May 2025 in “Journal of Inflammation Research” Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.
Survivors of severe COVID-19 need ongoing care to manage lasting health issues.
February 2025 in “Archives of Dermatological Research” Combining PRP with topical minoxidil is most effective for hair growth in androgenetic alopecia.
February 2025 in “Journal of the European Academy of Dermatology and Venereology” Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.
January 2025 in “Journal of Plastic Reconstructive & Aesthetic Surgery” Two L-PRP treatments improve hair density in mild to moderate alopecia.
January 2025 in “Recent Patents on Anti-Cancer Drug Discovery” The treatment showed high response rates and was well-tolerated, potentially extending patient survival.
January 2025 in “International Journal of Scientific Research” 12.5% of women with PCOS experience moderate hair loss, highlighting the need for early detection and management.